Barclays’s Exicure XCUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-573
Closed -$6K 5177
2022
Q2
$6K Buy
573
+446
+351% +$9.38K ﹤0.01% 4759
2022
Q1
$4K Hold
127
﹤0.01% 4735
2021
Q4
$4K Sell
127
-53
-29% -$6.15K ﹤0.01% 4036
2021
Q3
$33K Buy
180
+10
+6% +$2.03K ﹤0.01% 4239
2021
Q2
$39K Sell
170
-287
-63% -$75.2K ﹤0.01% 4249
2021
Q1
$149K Buy
457
+139
+44% +$47.8K ﹤0.01% 3836
2020
Q4
$85K Buy
318
+138
+77% +$34.5K ﹤0.01% 4203
2020
Q3
$48K Sell
180
-37
-17% -$12.1K ﹤0.01% 4620
2020
Q2
$79K Buy
+217
New +$78.6K ﹤0.01% 4676

Other funds holding XCUR

Barclays's XCUR Position: Q3 2022 in Review

Barclays sold out of Exicure (XCUR) in Q3 2022, closing a stake of 573 shares — an estimated $6K sold.

Barclays first reported a position in XCUR in Q2 2020 and held it in 9 quarters. The position peaked at $149K in Q1 2021. 17 funds tracked by Wall St. Rank hold XCUR as of Q3 2022.

  • Barclays reported no remaining Exicure position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 573 Exicure shares in Q3 2022, an estimated $6K.
  • Barclays first reported a position in Exicure in Q2 2020 and held it in 9 quarters.
  • Barclays's Exicure position peaked at $149K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Exicure as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.